AMEX:XBI   SPDR Series Trust SPDR S&P Biotech ETF
After a whole year of just performing like trash, XBI is now at covid levels. It literally gave up all the gains it made in 2020 in 2021.
It is currently at a monthly SR level and volume area, while also being at the long term trendline. I'm expecting this to turn around and at least hit ~$115 again, but who knows, it's the XBI after all.

Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.